Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Canaan Partners
Biotech
Recursion, Canaan, Metsera and more—Chutes & Ladders
Recursion plucks J&J chief data science officer. Canaan adds ex-Pfizer R&D leader as venture partner. Obesity-focused Metsera unveils leadership team.
Max Bayer
,
Gabrielle Masson
Apr 19, 2024 8:30am
Canaan adds $100M-plus, Pfizer vet to guide fresh biotech bets
Apr 17, 2024 7:00am
Qlaris, with $25M round, pushes new glaucoma drug into clinic
Apr 15, 2021 7:30am
Tyra banks $106M, adds to C-suite as it aims for clinic in 2022
Mar 31, 2021 11:00am
Day One banks $130M to advance pan-RAF inhibitor
Feb 10, 2021 9:40am
Vivace snares $30M to push Hippo-targeting drugs into clinic
Dec 16, 2020 11:00am